New asthma shot aims to tame dangerous Flare-Ups
NCT ID NCT07456033
Summary
This study is testing whether adding a new injectable medication called depemokimab to standard asthma care can better control severe asthma. It will involve about 456 adults and teenagers with a specific type of asthma (Type 2) who are at high risk of serious flare-ups. The main goal is to see if the treatment reduces the number of times participants need steroid pills for asthma attacks and helps them achieve long-term remission.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.